A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/21/2006	WO2006134609A2 Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof
12/21/2006	WO2006134604A1 Combination composition of cholesterol absorption inhibitor and 3-hydroxy-3-methylglutaryl-coenzyme a (hmg-coa) reductase inhibitor
12/21/2006	WO2006134600A1 Compounds useful for treating bipolar disorders
12/21/2006	WO2006134591A2 Use of allylmercaptocaptopril for treating or preventing obesity and obesity related diseases
12/21/2006	WO2006134492A2 Acarbose methods and formulations for treating chronic constipation
12/21/2006	WO2006134491A2 New crystalline form of moxifloxacin hydrochloride and process for its preparation
12/21/2006	WO2006134489A1 Sulindac derivatives for treatment of cancer
12/21/2006	WO2006134487A1 3-phenylazetidine derivatives as dopamine agonists
12/21/2006	WO2006134486A2 Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as orl1-receptor antagonists
12/21/2006	WO2006134485A1 Alpha-(aryl-or heteroaryl-methyl)-beta-piperidinopropanoic acid compounds as orl1-receptor antagonists
12/21/2006	WO2006134481A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
12/21/2006	WO2006134467A1 N-(pyridin-2-yl)-sulfonamide derivatives
12/21/2006	WO2006134466A1 Substituted arylpyrazoles as parasiticidal agents
12/21/2006	WO2006134460A1 Chromane substituted benzimidazole derivatives as acid pump antagonists
12/21/2006	WO2006134459A1 Substituted arylpyrazoles
12/21/2006	WO2006134431A1 Formate salt of gemifloxacin
12/21/2006	WO2006134409A2 Synergistic prebiotic compositions
12/21/2006	WO2006134406A1 Stable pharmaceutical gel of diclofenac sodium
12/21/2006	WO2006134385A2 Anti-inflammatory agents
12/21/2006	WO2006134384A1 Anti-inflammatory agents
12/21/2006	WO2006134382A1 N-(2, 2-dimethylpropyl) -6- (3-fluoro-5- ( (3-isoxazolylamino) carbonyl) -2-methylpheny l) -3-pyridinecarboxamide
12/21/2006	WO2006134341A1 Therapeutic agents
12/21/2006	WO2006134318A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
12/21/2006	WO2006134317A1 Oxadiazole derivatives as dgat inhibitors
12/21/2006	WO2006134279A2 Method for solubilizing metronidazole
12/21/2006	WO2006134272A1 Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle
12/21/2006	WO2006134203A1 Compounds for treating or preventing amine oxidase related diseases or disorders
12/21/2006	WO2006134167A1 Steroids having a mixed androgenic and progestagenic profile
12/21/2006	WO2006134160A2 Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives)
12/21/2006	WO2006134150A1 Benzofuranyl derivatives as 5-ht6-receptor inhibitors
12/21/2006	WO2006134146A1 Orthopaedic skeletal demonstration aids
12/21/2006	WO2006134133A1 Installation for guiding a gas for devices used to treat granular products by drying, film-coating or coating, especially an incoming air unit, and device comprising one such installation
12/21/2006	WO2006134120A1 Mixtures comprising anthranilic acid amides and cooling agents as cosmetic and pharmaceutical compositions for alleviating itching
12/21/2006	WO2006134112A1 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors
12/21/2006	WO2006134111A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion
12/21/2006	WO2006134040A1 Anthranilic acid derivatives
12/21/2006	WO2006134022A1 Mrp iv inhibitors for the treatment of respiratory diseases
12/21/2006	WO2006134021A2 Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
12/21/2006	WO2006134013A1 Mixtures comprising anthranilic acid amides and cooling agents as cosmetic and pharmaceutical compositions for alleviating itching
12/21/2006	WO2006133954A2 Diclofenac formulations and methods of use
12/21/2006	WO2006133946A1 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators
12/21/2006	WO2006133945A1 Novel compounds
12/21/2006	WO2006133943A1 Nuclear receptors agonists for treatment of atherosclerosis and/or related cardiovascular disease
12/21/2006	WO2006133942A1 NOVEL SALT FORM OF A β2 -ADRENERGIC AGONIST QUINOLIN-2-ONE DERIVATIVE
12/21/2006	WO2006133941A2 Cannabinoid active pharmaceutical ingredient for improved dosage forms
12/21/2006	WO2006133931A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening
12/21/2006	WO2006133926A1 Pyrazole derivates as cannabinoid receptor modulators
12/21/2006	WO2006133885A1 Tricyclic fused indole derivatives and their use as aurora kinase inhibitors
12/21/2006	WO2006133828A1 Novel use 25-hydroxycholecalciferol in combination with uv-b screening agents
12/21/2006	WO2006133821A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
12/21/2006	WO2006133805A1 Tetrahydroquinoline derivatives
12/21/2006	WO2006133802A1 N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as ccr1 antagonists
12/21/2006	WO2006133784A1 Use of substituted piperazine derivatives and morpholine derivatives
12/21/2006	WO2006133691A1 Method for determining and influencing the fertility of male mammals and of a human being
12/21/2006	WO2006133654A1 USE OF NF-κB INHIBITOR FOR TREATING SEVERAL DISEASES
12/21/2006	WO2006133652A1 Compounds, preparation process, and uses thereof used for interrupting reuptake of 5-hydroxytryptamine and norepinephrine or treating diseases such as depression et al.
12/21/2006	WO2006133634A1 Tetrahydroindole derivatives and tetrahydroindazole derivatives, and use thereof
12/21/2006	WO2006133632A1 Nucleotide analogue prodrug and the preparation thereof
12/21/2006	WO2006133612A1 A chinese medicine capsule formulation for treating stroke and preparation method thereof
12/21/2006	WO2006133611A1 N2-quinolyl or isoquinolyl substituted purine derivatives, the preparation and uses thereof
12/21/2006	WO2006133588A1 ARYL UREA COMPOUNDS AS β-SECRETASE INHIBITORS
12/21/2006	WO2006133567A1 Helix 12 directed non-steroidal antiandrogens
12/21/2006	WO2006133561A1 Method of cancer treatment using sirna silencing
12/21/2006	WO2006133559A1 Reversible inhibitors of monoamine oxidase a and b
12/21/2006	WO2006133543A1 Diet supplements for weight loss, daytime energy and night time relaxation
12/21/2006	WO2006133533A1 A treatment for short bowel syndrome
12/21/2006	WO2006133510A1 Liquid pharmaceutical formulations of docetaxel
12/21/2006	WO2006133506A1 A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
12/21/2006	WO2006133498A1 Acid addition salts of n-ethyi-n'-[2-methoxy-4-(5-methyi-4-{[(1s)-1-pyridin-3-ylbutyi]amino}pyrimidin- 2-yl)phenyl]urea and uses thereof
12/21/2006	WO2006133497A1 Combination treatment
12/21/2006	WO2006121666A3 Delivery of tigecycline in the presence of warfarin
12/21/2006	WO2006118605A3 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
12/21/2006	WO2006117885A8 External preparation for skin
12/21/2006	WO2006116626A3 Methods and compositions for treating pain
12/21/2006	WO2006116399A3 Use of novel compounds for ibd treatment
12/21/2006	WO2006116169A3 Methods for modulating bladder function
12/21/2006	WO2006114604A3 Water-soluble films comprising nicotine
12/21/2006	WO2006110588A3 Methods for treating mild cognitive impairment
12/21/2006	WO2006106311A3 Combination treatment methods for treating sex-hormone dependent disease and fertility treatment
12/21/2006	WO2006105194A3 Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
12/21/2006	WO2006104997A3 Tartaric acid salts of a dipeptidyl peptidase-iv inhibitor
12/21/2006	WO2006103407A3 New pharmaceutical compositions useful in the treatment of migraine
12/21/2006	WO2006102446A3 Multi-particulate, modified-released colonic composition
12/21/2006	WO2006099865A3 Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo
12/21/2006	WO2006099015A3 Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders
12/21/2006	WO2006097793A3 Compositions capable of facilitating penetration across a biological barrier
12/21/2006	WO2006097293A3 Combination of a steroid sulfatase inhibitor and an ascomycin
12/21/2006	WO2006094201A3 Semicarbazide-sensitive amide oxidase inhibitors
12/21/2006	WO2006094064A3 Method of reducing scars with vitamin d
12/21/2006	WO2006093957A3 Blood soluble drag reducing hyaluronic acid
12/21/2006	WO2006092599A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/21/2006	WO2006089658A3 Nk1 antagonists
12/21/2006	WO2006089656A3 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
12/21/2006	WO2006089276A3 Pharmacokinetically improved compounds
12/21/2006	WO2006089275A3 Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds
12/21/2006	WO2006089076A3 Thiazole amides, imidazole amides and related analogues
12/21/2006	WO2006089009A3 Methods and compositions for the treatment of lipid-associated disorders
12/21/2006	WO2006088476A3 Carboranylporphyrins and uses thereof
12/21/2006	WO2006087548A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/21/2006	WO2006087544A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors

1 ... 3954 3955 3956 3957 3958 3959 3960 3961 3962 3963 3964 3965 3966 3967 3968 3969 3970 3971 3972 3973 3974 ... 7860